# US 2024/0189301 A1 · Methods and compositions for maintaining opioid efficacy in the treatment of pain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189301 A1
- Document ID: US20240189301A1
- Status: Published application
- Kind: A1
- Application number: 18/443,447
- Filed: 2024-02-16
- Published: 2024-06-13
- Earliest claimed: 2017-10-26
- Assignees: East Carolina University
- Applicants: East Carolina University
- Inventors: Kori Brewer; Stefan Clemens
- Web page: https://patentgrep.com/patent/US20240189301A1

## CPC

- A61K 31/485: Morphinan derivatives, e.g. morphine, codeine
- A61P 25/36: Opioid-abuse
- A61K 31/428: condensed with carbocyclic rings
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides methods for treating and/or managing pain. The invention further provides methods for reducing or inhibiting opioid tolerance, reducing risk of opioid addiction or dependence, restoring opioid efficacy, and enhancing the therapeutic effect of an opioid. The invention further provides compositions for use in the methods of the invention.

## Claims

### Claim 1

A method of treating pain in a subject in need thereof, comprising administering to the subject an effective amount of an opioid and a dopamine type 3 receptor (D3R) agonist, thereby treating pain in the subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the pain is chronic pain.

### Claim 3 (depends on 1)

The method of claim 1, wherein the pain is acute pain.

### Claim 4

A method of reducing or inhibiting opioid tolerance in a subject in need thereof, comprising administering to the subject an effective amount of an opioid and a dopamine type 3 receptor (D3R) agonist, thereby reducing or inhibiting opioid tolerance in the subject.

### Claim 5

A method of reducing risk of opioid addiction or dependence in a subject in need thereof, comprising administering to the subject an effective amount of an opioid and a dopamine type 3 receptor (D3R) agonist, thereby reducing risk of opioid addiction or dependence in the subject.

### Claim 6

A method of restoring opioid efficacy in a subject in need thereof, comprising administering to the subject an effective amount of an opioid and a dopamine type 3 receptor (D3R) agonist, thereby restoring opioid efficacy in the subject.

### Claim 7

A method for enhancing the therapeutic effect of an opioid in a subject, comprising:
a) administering an effective amount of a D3R agonist to a subject; and
b) administering a subtherapeutic amount of the opioid to the subject,
wherein the therapeutic effect of the subtherapeutic amount of the opioid is enhanced as compared to the effect of the subtherapeutic amount of the opioid administered without the D3R agonist.

### Claim 8 (depends on 1)

The method of claim 1, wherein the D3R agonist and the opioid are administered in the same composition.

### Claim 9 (depends on 1)

The method of claim 1, wherein the D3R agonist and the opioid are administered in separate compositions.

### Claim 10 (depends on 9)

The method of claim 9, wherein the D3R agonist and the opioid are administered by the same route.

### Claim 11 (depends on 9)

The method of claim 9, wherein the D3R agonist and the opioid are administered by different routes.

### Claim 12 (depends on 1)

The method of claim 1, wherein the D3R agonist and the opioid are administered via one or more of oral administration, injection, patch, and a surgically implanted pump.

### Claim 13 (depends on 1)

The method of claim 1, further comprising delivering to the subject an additional therapeutic agent.

### Claim 14 (depends on 13)

The method of claim 13, wherein the additional therapeutic agent is an analgesic.

### Claim 15 (depends on 1)

The method of claim 1, wherein the subject is a human.

### Claim 16

A composition comprising:
(a) at least one opioid;
(b) at least one dopamine type 3 receptor agonist; and
(c) a pharmaceutically acceptable carrier, excipient or diluent.

### Claim 17

A kit for treating pain, comprising at least one opioid and at least one dopamine type 3 receptor agonist.
